Breaking News Instant updates and real-time market news.

ESPR

Esperion

$45.00

-1.15 (-2.49%)

12:35
10/15/18
10/15
12:35
10/15/18
12:35

Esperion put volume heavy and directionally bearish

Bearish flow noted in Esperion with 1,497 puts trading, or 1.6x expected. Most active are Oct-18 30 puts and Oct-18 35 puts, with total volume in those strikes near 1,200 contracts. The Put/Call Ratio is 7.16, while ATM IV is up over 4 points on the day. Earnings are expected on November 6th.

ESPR Esperion
$45.00

-1.15 (-2.49%)

09/13/18
STFL
09/13/18
INITIATION
STFL
Buy
Esperion resumed with a Buy at Stifel
Stifel analyst Derek Archila resumed coverage of Esperion with a Buy rating and $89 price target, saying he is positively biased heading into bempedoic acid's Study 2 results expected in October. Archila believes the death imbalance for fatal adverse events unrelated to drug is "most likely noise", the controversy surrounding increases in liver function tests is "overblown", and there is a "clear role for BPA and BPA/ezetimibe within their treatment armamentarium for statin intolerant/uncontrolled patients."
08/17/18
08/17/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. NVIDIA UPGRADED AMID POST-EARNINGS PULLBACK: Oppenheimer analyst Rick Schafer upgraded Nvidia to Outperform from Perform following Thursday's earnings, noting that all its segments grew year-over-year, led by core Gaming and Data Center. While its Q3 outlook was mixed, he attributes the modest top-line guidance miss to a slowdown in crypto demand and lack of volume availability of the recently introduced Turing gaming GPU. Schafer, who he sees significant pent-up demand for Turing along with solid, structural growth drivers in Data Center AI, gaming and autonomous, set a $310 price target on Nvidia shares, which are down 4.3% to $246.27 in morning trading. CITI SAY BUY ESPERION AHEAD OF EXPECTED CHOLESTEROL DRUG APPROVAL: Citi analyst Joel Beatty upgraded Esperion to Buy from Neutral because he believes bempedoic acid for LDL-lowering is likely to be approved. His 70% probability of approval view is higher than the roughly 40% odds of success he believes is currently priced in the stock, Beatty tells investors. DSW CUT TO NEGATIVE: Susquehanna analyst Sam Poser downgraded DSW to Negative from Neutral as he expects margins to be challenged due to increased variable costs and gross margin pressure related to the new loyalty program. He also expects guidance to be reduced following the next earnings call. Poser lowered his price target to $22 from $26 on DSW shares, which are down 7.3% in morning trading. DEUTSCHE MORE POSITIVE ON MATCH GROUP: Deutsche Bank analyst Kunal Madhukar believes the total addressable market for Match Group's Tinder could be in the range of 185-190M monthly average users, which could translate into about 10M paying subscribers for Tinder, and he contends that Tinder remains underpenetrated relative to that opportunity. Given his higher confidence in Tinder's ability to keep delivering strong growth over the medium-term, Madhukar reiterated his Buy rating on Match Group and increased his price target on the shares to $56 from $50.
08/17/18
08/17/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Nvidia (NVDA) upgraded to Outperform from Perform at Oppenheimer with analyst Rick Schafer noting that all its segments grew year-over-year, led by core Gaming and Data Center. 2. Esperion (ESPR) upgraded to Buy from Neutral at Citi with analyst Joel Beatty saying he believes bempedoic acid for LDL-lowering is likely to be approved. 3. Viper Energy (VNOM) upgraded to Buy from Hold at Stifel with analyst Timothy Howard saying he believes the MLP will be a significant beneficiary of parent Diamondback Energy's (FANG) acquisition of Energen (EGN). 4. First Data (FDC) upgraded to Overweight from Neutral at Atlantic Equities with analyst Kunaal Malde saying its prior acquisitions of CardConnect and BluePay have given it a foothold in higher growth segments and the company is now "on a clear path to deleveraging." 5. Fluor (FLR) upgraded to Buy from Hold at Canaccord. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/17/18
08/17/18
UPGRADE
Target $75

Buy
Esperion upgraded to Buy on 70% odds for bempedoic acid approval at Citi
As previously reported, Citi analyst Joel Beatty upgraded Esperion to Buy from Neutral because he believes bempedoic acid for LDL-lowering is likely to be approved. His 70% probability of approval view is higher than the roughly 40% odds of success he believes is currently priced in the stock, Beatty tells investors. His increased price target of $75, up from $57 previously, assumes $1.2B in bempedoic acid sales in 2025, Beatty noted.

TODAY'S FREE FLY STORIES

AKAM

Akamai

$91.72

0.15 (0.16%)

13:35
10/21/19
10/21
13:35
10/21/19
13:35
Hot Stocks
Akamai says peak traffic on Akamai intelligent edge platform exceeds 100 Tbps »

Akamai announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 05

    Nov

  • 06

    Nov

  • 19

    Nov

  • 09

    Dec

VRTX

Vertex

$176.23

-0.01 (-0.01%)

13:29
10/21/19
10/21
13:29
10/21/19
13:29
Hot Stocks
Vertex says Spanish government approves national reimbursement of CF combos »

Vertex Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

STRM

Streamline Health

$1.20

0.02 (1.69%)

, AGO

Assured Guaranty

$47.16

0.28 (0.60%)

13:19
10/21/19
10/21
13:19
10/21/19
13:19
On The Fly
Fly Insider: Streamline, Proofpoint among week's notable insider trades »

Welcome to "Fly Insider,"…

STRM

Streamline Health

$1.20

0.02 (1.69%)

AGO

Assured Guaranty

$47.16

0.28 (0.60%)

TAYD

Taylor Devices

$10.72

0.21 (2.00%)

CMCT

CIM Commercial Trust

$14.70

0.1 (0.68%)

ATNX

Athenex

$9.81

-0.39 (-3.82%)

OKTA

Okta

$101.00

2.32 (2.35%)

LRCX

Lam Research

$239.22

5.56 (2.38%)

FISV

Fiserv

$104.30

-1.41 (-1.33%)

PFPT

Proofpoint

$120.13

0.7 (0.59%)

ANET

Arista Networks

$245.27

5.57 (2.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 27

    Oct

  • 31

    Oct

  • 05

    Nov

  • 05

    Nov

  • 06

    Nov

  • 06

    Nov

  • 06

    Nov

  • 08

    Nov

  • 12

    Nov

  • 13

    Nov

  • 13

    Nov

  • 19

    Nov

  • 20

    Nov

  • 09

    Dec

  • 12

    Dec

  • 16

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
10/21/19
10/21
13:17
10/21/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
10/21/19
10/21
13:16
10/21/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRM

Iron Mountain

$33.96

0.44 (1.31%)

13:15
10/21/19
10/21
13:15
10/21/19
13:15
Options
Iron Mountain put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 12

    Nov

BA

Boeing

$333.70

-10.39 (-3.02%)

13:05
10/21/19
10/21
13:05
10/21/19
13:05
Periodicals
Boeing CEO cites 'steady progress' on 737 MAX in internal email, Reuters says »

Boeing's CEO said in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

FTCH

Farfetch

$8.18

0.15 (1.87%)

13:05
10/21/19
10/21
13:05
10/21/19
13:05
Options
Farfetch Limited call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$299.80

1.815 (0.61%)

13:04
10/21/19
10/21
13:04
10/21/19
13:04
Periodicals
POTUS says trade pact with China coming along great, Reuters says »

U.S. President Donald…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$299.80

1.815 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$118.45

0.96 (0.82%)

, MCD

McDonald's

$209.91

1.43 (0.69%)

13:03
10/21/19
10/21
13:03
10/21/19
13:03
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PG

Procter & Gamble

$118.45

0.96 (0.82%)

MCD

McDonald's

$209.91

1.43 (0.69%)

UTX

United Technologies

$138.27

1.42 (1.04%)

NEE

NextEra Energy

$231.47

-1.21 (-0.52%)

LMT

Lockheed Martin

$373.98

1.36 (0.36%)

UPS

UPS

$119.05

1.72 (1.47%)

SHW

Sherwin-Williams

$559.43

-1.54 (-0.27%)

KMB

Kimberly-Clark

$138.03

0.73 (0.53%)

BIIB

Biogen

$224.66

4.61 (2.10%)

TRV

Travelers

$141.76

0.32 (0.23%)

PCAR

Paccar

$73.44

1.39 (1.93%)

FITB

Fifth Third

$27.91

0.575 (2.10%)

CNC

Centene

$46.98

0.06 (0.13%)

RF

Regions Financial

$16.08

0.3 (1.90%)

NUE

Nucor

$52.25

0.56 (1.08%)

HAS

Hasbro

$120.60

-1.29 (-1.06%)

TRU

TransUnion

$82.01

0.52 (0.64%)

DGX

Quest Diagnostics

$102.55

-0.12 (-0.12%)

IPG

Interpublic Group

$20.69

0.04 (0.19%)

HOG

Harley-Davidson

$37.11

0.53 (1.45%)

PII

Polaris Industries

$92.01

1.395 (1.54%)

SNV

Synovus

$36.36

1.07 (3.03%)

JBLU

JetBlue

$17.63

0.675 (3.98%)

GPK

Graphic Packaging

$15.01

0.355 (2.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 04

    Nov

  • 07

    Nov

  • 10

    Nov

  • 10

    Nov

  • 10

    Nov

  • 12

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 19

    Nov

  • 04

    Dec

  • 07

    Dec

BMRN

BioMarin

$68.98

-0.18 (-0.26%)

13:03
10/21/19
10/21
13:03
10/21/19
13:03
Hot Stocks
BioMarin treatment of phenylketonuria granted FDA orphan status »

BioMarin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 23

    Oct

  • 07

    Dec

UPS

UPS

$119.07

1.74 (1.48%)

, FDX

FedEx

$153.86

3.97 (2.65%)

13:00
10/21/19
10/21
13:00
10/21/19
13:00
Earnings
Fly Intel: What to watch in UPS earnings report »

UPS (UPS) is scheduled to…

UPS

UPS

$119.07

1.74 (1.48%)

FDX

FedEx

$153.86

3.97 (2.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

  • 13

    Nov

  • 17

    Dec

AMTD

TD Ameritrade

$37.85

1.06 (2.88%)

, CDNS

Cadence Design

$66.73

1.13 (1.72%)

12:59
10/21/19
10/21
12:59
10/21/19
12:59
Earnings
Notable companies reporting after market close »

Notable companies…

AMTD

TD Ameritrade

$37.85

1.06 (2.88%)

CDNS

Cadence Design

$66.73

1.13 (1.72%)

CE

Celanese

$122.11

0.44 (0.36%)

ZION

Zions Bancorp

$45.40

0.68 (1.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 21

    Oct

  • 22

    Oct

  • 22

    Oct

  • 06

    Nov

  • 19

    Nov

EL

Estee Lauder

$186.09

0.44 (0.24%)

12:56
10/21/19
10/21
12:56
10/21/19
12:56
Downgrade
Estee Lauder rating change  »

Estee Lauder downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 31

    Oct

  • 15

    Nov

12:50
10/21/19
10/21
12:50
10/21/19
12:50
General news
Treasury's agenda for the November refunding meeting wanted dealer insights »

Treasury's agenda…

FB

Facebook

$189.22

3.265 (1.76%)

12:49
10/21/19
10/21
12:49
10/21/19
12:49
Hot Stocks
Facebook updates inauthentic behavior policy to counter new tactics »

Facebook said in a post…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

FB

Facebook

$189.22

3.265 (1.76%)

12:48
10/21/19
10/21
12:48
10/21/19
12:48
Hot Stocks
Facebook launches 'Protect' to secure accounts of elected officials »

Facebook announced on its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

OPOF

Old Point Financial

$24.61

(0.00%)

12:46
10/21/19
10/21
12:46
10/21/19
12:46
Hot Stocks
Old Point Financial appoints Elizabeth Beale CFO »

Elizabeth Beale has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOS

Mosaic

$19.72

0.16 (0.82%)

12:45
10/21/19
10/21
12:45
10/21/19
12:45
Options
Mosaic call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 13

    Nov

INFO

IHS Markit

$69.67

-0.08 (-0.11%)

12:41
10/21/19
10/21
12:41
10/21/19
12:41
Conference/Events
IHS Markit management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 23

    Oct

MSFT

Microsoft

$137.79

0.45 (0.33%)

12:36
10/21/19
10/21
12:36
10/21/19
12:36
Hot Stocks
Microsoft acquires cloud file migration provider Mover; terms not disclosed »

Jeff Teper, CVP Office,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 26

    Oct

  • 27

    Oct

  • 29

    Oct

  • 06

    Nov

  • 21

    Nov

DEST

Destination Maternity

$0.20

-0.136 (-40.48%)

12:27
10/21/19
10/21
12:27
10/21/19
12:27
Periodicals
Destination Maternity plans bankruptcy filing in next few weeks, CNBC reports »

Destination Maternity is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAGS

PagSeguro Digital

$39.14

0.305 (0.79%)

12:25
10/21/19
10/21
12:25
10/21/19
12:25
Options
PagSeguro Digital call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

  • 17

    Dec

GSK

GlaxoSmithKline

$42.46

-0.06 (-0.14%)

12:20
10/21/19
10/21
12:20
10/21/19
12:20
Hot Stocks
GlaxoSmithKline to divest rabies, tick-borne encephalitis vaccines »

GlaxoSmithKline announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 30

    Oct

  • 07

    Dec

12:20
10/21/19
10/21
12:20
10/21/19
12:20
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.